Reuters: Global Markets: ICU Medical first-quarter results beat Street on strong sales

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

ICU Medical first-quarter results beat Street on strong sales Apr 16th 2012, 20:57 Mon Apr 16, 2012 4:57pm EDT (Reuters) - ICU Medical Inc's (ICUI.O) quarterly profit beat estimates for the fourth straight quarter as its infusion therapy and cancer care systems continued to sell robustly. For the full year, ICU reaffirmed its earnings outlook of $2.45 per share to $2.70 per share. The company, which makes medical connection systems for use in intravenous therapy applications, said it expects full-year revenue of $318 million to $330 million. Analysts polled by Thomson Reuters I/B/E/S were expecting full-year earnings of 2.56 per share on revenue of $321.9 million. First-quarter profit was $7.6 million, or 53 cents per share, compared with $8.1 million, or 57 cents per share, in the year-ago quarter. Analysts were expecting earnings of 48 cents per share. Revenue rose 5.7 percent to $75.5 million, slightly exceeding analysts' expectations of $74.6 million, buoyed by a 30 percent revenue rise in the oncology products segment. The San Clemente, California-based company's shares closed at $49.02 on Monday on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions